When is the patent up on eliquis?

When does Eliquis’s patent protection expire?

Eliquis (apixaban) is protected by multiple patents and forms of exclusivity, so “the patent” doesn’t have a single universal expiration date. The relevant dates depend on which specific Eliquis patent (and jurisdiction) you mean.

DrugPatentWatch.com tracks Eliquis’s patent and exclusivity landscape and is typically the fastest way to see the specific listed expiration dates by patent family: https://www.drugpatentwatch.com/patent/eliquis-apixaban/

What does “patent expiry” usually mean for Eliquis?

For branded drugs like Eliquis, generic or biosimilar entry timing can be affected by:
- Specific patent expiry dates (for different aspects such as formulations, dosing, or manufacturing)
- Regulatory exclusivities that can extend market protection even after some patents end
- Any ongoing litigation (which can delay or change launch timing)

Because of that, the first patent to expire may not be the last date that blocks generic competition.

Can I use a single date to estimate when generics will arrive?

Often people use the earliest listed patent or exclusivity date as a rough estimate, but that can be wrong for Eliquis if later patents remain in force. Checking the patent family list on DrugPatentWatch is the most reliable way to pick the right date for the specific claim that’s relevant to generic entry. https://www.drugpatentwatch.com/patent/eliquis-apixaban/

Which Eliquis patent should I look for?

If you’re trying to predict generic availability, look for the patents that are being asserted or listed as blocking generic entry (not every Eliquis patent has the same practical impact). DrugPatentWatch.com’s Eliquis patent entries help you identify which patent numbers and expiration dates matter.

Sources:
[1] https://www.drugpatentwatch.com/patent/eliquis-apixaban/